Cryo-Cell International, Inc.

NYSE American:CCEL

Sector

🏥 Health Care

Industries

🧬 Biotechnology

🔬 Clinical Trials

🔍 Research & Consulting

Location

United States

Market Cap

USD 39.88 M

Share Price

USD 4.91

Avg Daily Volume

10,512

Change (1 day)

0.20%

Change (1 year)

-29.86%

Change (YTD)

-33.74%

Cryo-Cell International, Inc. EBIT Margin for the Trailing 12 Months (TTM) ending May 31, 2025: 6.60%

Cryo-Cell International, Inc. EBIT Margin is 6.60% for the Trailing 12 Months (TTM) ending May 31, 2025, a -119.52% change year over year. EBIT ratio is the ratio of EBIT to revenue, measuring a company's operating profitability without considering non-operating income or expenses.

Cryo-Cell International, Inc. EBIT Margin for the Trailing 12 Months (TTM) ending May 31, 2024 was -33.79%, a -356.78% change year over year.
Cryo-Cell International, Inc. EBIT Margin for the Trailing 12 Months (TTM) ending May 31, 2023 was 13.16%, a 14.56% change year over year.
Cryo-Cell International, Inc. EBIT Margin for the Trailing 12 Months (TTM) ending May 31, 2022 was 11.49%, a -49.76% change year over year.
Cryo-Cell International, Inc. EBIT Margin for the Trailing 12 Months (TTM) ending May 31, 2021 was 22.86%, a 8.53% change year over year.